Cargando…
Positive antiphospholipid antibodies: observation or treatment?
Antiphospholipid antibodies (APLAs) are primarily directed toward phospholipid-binding proteins and are responsible for thrombotic events. APLAs include anti-β2Glycoprotein I (anti-β2GPI), anticardiolipin (anti-CL) antibodies, and lupus anticoagulant. These antibodies are typical markers of antipho...
Autores principales: | Grygiel-Górniak, Bogna, Mazurkiewicz, Łukasz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234248/ https://www.ncbi.nlm.nih.gov/pubmed/37264223 http://dx.doi.org/10.1007/s11239-023-02834-6 |
Ejemplares similares
-
Clinical implications of systemic lupus erythematosus without and with antiphospholipid syndrome in peri- and postmenopausal age
por: Grygiel-Górniak, Bogna, et al.
Publicado: (2018) -
Antinuclear antibodies in healthy people and non-rheumatic diseases – diagnostic and clinical implications
por: Grygiel-Górniak, Bogna, et al.
Publicado: (2018) -
Antimalarial drugs—are they beneficial in rheumatic and viral diseases?—considerations in COVID-19 pandemic
por: Grygiel-Górniak, Bogna
Publicado: (2021) -
Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications – a review
por: Grygiel-Górniak, Bogna
Publicado: (2014) -
Antinuclear antibodies in autoimmune and allergic diseases
por: Grygiel-Górniak, Bogna, et al.
Publicado: (2017)